US Stock MarketDetailed Quotes

GSK GlaxoSmithKline

Watchlist
  • 32.700
  • -0.390-1.18%
Close Jan 13 16:00 ET
  • 32.800
  • +0.100+0.31%
Post 19:32 ET
66.72BMarket Cap22.06P/E (TTM)

GlaxoSmithKline Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

GlaxoSmithKline Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: GBP

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 7.510B--
--2024/Q4-- / 7.681B--
Oct 30, 20242024/Q38.012B / 8.007B--
Jul 31, 20242024/Q27.884B / 7.493B--
May 1, 20242024/Q17.363B / 7.060B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 7.510B--
--2024/Q4-- / 7.681B--
Oct 30, 20242024/Q38.012B / 8.007B--
Jul 31, 20242024/Q27.884B / 7.493B--
May 1, 20242024/Q17.363B / 7.060B--

Unlock Free Earnings Estimates

GlaxoSmithKline Earnings Reports

  • 6-K: Gsk on track to deliver 2024 outlooks with further good progress made in r&d

    Oct 30, 2024 11:27 ET

  • 6-K: Gsk Delivers Continued Strong Performance and Upgrades 2024 Guidance

    Jul 31, 2024 12:31 ET

  • 6-K: Gsk Makes a Strong Start to 2024 with Improving Outlook for the Year

    May 1, 2024 12:34 ET

  • GlaxoSmithKline | 6-K: Glaxosmithkline 2023 Annual Report on Form 20-F

    Mar 5, 2024 13:13 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 31, 2024

    Hold

    • Buy

      20.00%

    • Hold

      60.00%

    • Sell

      20.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data

    Investment Theme CAR-T Therapy
    CAR-T Therapy
    Intraday+1.03%
    Infectious Disease
    Infectious Disease
    Intraday+0.36%